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In most societies resources are insufficient to provide everyone with all the health care they 
want. In practice, this means that some people are given priority over others. On what basis 
should priority be given? In this paper we are interested in the general public’s views on this 
question. We set out to synthesis what the literature has found as a whole regarding which 
attributes or factors the general public think should count in priority setting and what weight 
they should receive. A systematic review was undertaken (in August 2014) to address these 
questions based on empirical studies that elicited stated preferences from the general public. 
Sixty four studies, applying eight methods, spanning five continents met the inclusion criteria. 
Discrete Choice Experiment (DCE) and Person Trade-off (PTO) were the most popular 
standard methods for preference elicitation, but only 34% of all studies calculated distributional 
weights, mainly using PTO. While there is heterogeneity, results suggest the young are 
favoured over the old, the more severely ill are favoured over the less severely ill, and people 
with self-induced illness or high socioeconomic status tend to receive lower priority. In those 
studies that considered health gain, larger gain is universally preferred, but at a diminishing 
rate. Evidence from the small number of studies that explored preferences over different 
components of health gain suggests life extension is favoured over quality of life enhancement; 
however this may be reversed at the end of life. The majority of studies that investigated end 
of life care found weak/no support for providing a premium for such care. The review 
highlights considerable heterogeneity in both methods and results. Further methodological 
work is needed to achieve the goal of deriving robust distributional weights for use in health 
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Countries around the world face the question of how best to set priorities in the allocation of 
scarce health resources. Traditionally, economic evaluation has been adopted as the preferred 
approach to guide policy making in such decisions, with the quality-adjusted life year (QALY), 
a metric of health gain that combines both quality of life and length of life, being the most-
commonly adopted measure of the value of a health care treatment (Drummond, 2013; 
Hjelmgren, et al., 2001). However, evidence from studies involving members of the public in 
various countries (Stafinski, et al., 2011; Whitty, et al., 2014a), from studies of past health 
technology assessment (HTA) decisions (Clement, et al., 2009; Devlin and Parkin, 2004; Harris, 
et al., 2008) and from HTA guidelines (Canadian Agency for Drugs Technologies in Health, 
2006; National Institute for Health and Clinical Excellence, 2008; Pharmaceutical Benefits 
Advisory Committee, 2013) suggests that QALY gain may not be the sole determinant of value. 
A key question is therefore what additional factors the general public (whose taxes contribute 
to funding health care) find important in resource allocation decisions? A second question is 
what distributional (or relative) weights these factors should receive in priority setting.  Such 
weights attach different (numerical) importance to QALYs based on the characteristics of the 
beneficiaries.   
These two questions have been explored extensively in the health economics research literature 
(the first more so than the second). However, little is known about what the literature, as a 
whole, has found regarding which factors or attributes the general public think should count, 
and to what extent, in health resource allocation decisions.  
This systematic review focuses on studies that have elicited stated preferences from the public 
as to what factors should count in allocating publicly-funded health care; and the weights to be 
attached to such factors. We address four questions: (1) which methods have been used to elicit 
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stated preferences for attributes considered important in priority setting?; (2) which attributes 
arise out of the application of such methods?; (3) which methods have been used to elicit 
distributional weights?; and (4) what are the estimated distributional weights?  
A small number of literature reviews on preferences in relation to priority setting have been 
conducted (Dolan, et al., 2005; Schwappach, 2002a; Shah, 2009; Stafinski, et al., 2011; Whitty, 
et al., 2014a; Youngkong, et al., 2009). In general they addressed our second question (an 
exception is Whitty, et al. (2014a) which also addressed our first question). However, to 
understand the differences between results about preferences it is necessary to understand how 
they were generated. Of importance too, after a large number of research studies, is whether a 
dominant approach has emerged for elicitation of preferences and weights, and whether a set 
of weights is ready for use in priority setting. 
Thus, this paper contributes to the literature by, first, addressing new and important questions 
and, second, more completely addressing questions previously considered. In contrast to 
previous reviews, we consider a broader range of attributes and summarise them under three 
categories: (a) the characteristics of beneficiaries of the health gain/health care; (b) the 
characteristics of health gain; and (c) other important contextual factors. We highlight the 
degree of consensus amongst the literature and, wherever possible, identify possible reasons 
for differences. We focus on studies using samples representing the general public based on 
age and gender. Our review covers a broader range of methods and, importantly, compares 
results from different methods. It is also the first to classify the perspectives used in each study 






PRISMA guidelines were used for the design of the review. The quality of studies included in 
the review was not evaluated because there is no single approach to assess the quality of the 
studies across the variety of methods used.  
2.2. Literature search 
Four databases were searched to ensure coverage across medicine and economics: Ovid 
Medline (1946 to present with daily update), Embase, Econlit and Web of Science (SCI-
expanded and SSCI) from conception to 13 August 2014. Search terms were developed for two 
categories: health care priority setting (defined as setting priorities in the context of the 
allocation of publicly-funded health care) and preferences and were initially developed for the 
Ovid Medline database then modified for each database. Studies not reported in English were 
excluded from the review during screening and eligibility assessment. The complete search 
strategy, including search terms, for all four databases is in Supplementary Appendix 1. 
Additional studies were identified via a hand search of the references and citations from the 
included articles. 
2.3. Eligibility criteria 
Inclusion/exclusion criteria are in Table 1. Further to above, included studies were peer 
reviewed and must have involved elicitation of stated preferences between competing criteria, 
interventions, or patient groups applicable to priority setting for publicly-funded health care. 
Studies should not be disease or treatment specific in order to identify generic attributes, 
although some included studies provided clinical information merely as part of the question 
framing. Studies were excluded if their sample came from subgroups of the general public due 
to the focus on studies using samples representative of the general public, particularly in terms 
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of age and gender. Studies using students do not provide such representativeness while those 
using small samples do. The inclusion/exclusion criteria were sequentially applied, starting 
with the language requirement and ending with the sample criterion.  
[INSERT TABLE 1] 
Two authors (YG and PG) independently screened the titles and abstracts of all studies 
identified from the search strategies. Full-texts of the studies included after the initial screening 
were also independently reviewed by these two authors. Discrepancies were resolved by 
discussion until a consensus was reached.  
2.4. Information extraction 
Data were extracted based on the four questions outlined in the introduction and also according 
to: (a) characteristics of beneficiaries of the health gain/health care; (b) characteristics of health 
gain; and (c) other important contextual factors. We note that classification into these three 
groups is subjective and other classifications are possible. 
3. Results 
3.1. Overview 
The process of study selection is summarised in Figure 1. The database and hand searches 
initially identified 4,504 studies, with 64 papers included in the review. Table 2 documents the 
complete list of studies (and attributes explored in each).  Their detailed summary are in 
Supplementary Appendix 2. 
[INSERT FIGURE 1] 
[INSERT TABLE 2] 
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The 64 studies spanned over two decades from 1989 to 2014, Figure 2 revealing an increasing 
trend during this period. This may also reflect that earlier studies were excluded because they 
used non-representative samples of the general public. Studies were mostly carried out in the 
UK (n=20), the US (n=11), and Australia (n=9). Sample sizes varied from 23 to 17,657 with a 
median of 556. Around 70% of studies used a sample size larger than 200, and 55% greater 
than 500 (See Supplementary Appendix 2).  
[INSERT FIGURE 2] 
3.2. Methods for stated preference elicitation 
Eight preference elicitation methods have been used, which we categorise as choice based 
techniques or ranking based techniques (see Figure 3). Choice based approaches have 
dominated the literature (used 62 times in 60 of the 64 studies) with ranking tasks used in 4 
studies. Within choice based approaches, DCE (including one best worst scaling study) has 
been used 17 times, PTO 15 times, choice tasks with bespoke design 15 times, simple choice 
tasks varying a single attribute 9 times, contingent valuation method (CVM) (or Willingness 
to Pay (WTP)) 5 times and a choice experiment with allocation of points once. The popularity 
of DCE has been increasing over time – 50% of studies using DCE have been conducted in the 
past five years while only a third of the total PTO studies were undertaken during that time.  
[INSERT FIGURE 3] 
Following Dolan, et al. (2003), the perspective framing used in the included studies was 
classified based on (1) whom the respondent was asked to think about (personal, impartial 
decision maker (excluding self), citizen (including self)) and (2) the point in time at which the 
preference was elicited (ex post, ex ante). Most studies did not explicitly state the perspective 
used and thus classification was largely based on our interpretation. We identified 66 
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perspectives from 63 studies (three studies included more than one perspective). One study did 
not provide any information about the question context so could not be classified (Lim, et al., 
2012). Thirteen of 65 perspectives were classified as impartial decision maker, three as citizen 
and four as personal. The remaining 46 could be either impartial decision maker or citizen 
depending on how respondents interpreted the context – we classified this as (non-specific) 
social perspective. The most commonly used timing perspective was ex post (58 times), 
followed by ex ante (7 times).  One study could not be classified due to inconsistent statements 
within the question context (Mortimer and Segal, 2008).   
3.3. Attributes and stated preferences 
In eliciting preferences, most studies attempted to control for confounding factors, either via 
wordings such as “all else being equal” or via explicitly fixing factors such as health gain and 
the cost of treatment. DCE studies typically included the health gain as an attribute. 
3.3.1. Characteristics of the beneficiaries 
Age 
Twenty-five studies (39%) elicited preferences for age. The majority (14 studies) suggest that 
the public in general favours the young over the elderly. However, preferences for age can be 
confounded by preferences for remaining life expectancy from a given age. If the confounding 
effect is controlled for, then the preference can be interpreted as preference for age per se; 
otherwise the preference for age may be conflated with preferences for remaining life 
expectancy. Among the 14 studies, eight controlled for the confounding effect (Dolan and 
Tsuchiya, 2005; Dolan and Tsuchiya, 2012; Johri, et al., 2009; Lewis and Charny, 1989; Nord, 
et al., 1996; Olsen, 2013; Schwappach and Strasmann, 2006; Tsuchiya, et al., 2003) while the 
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remaining six did not. In the latter case, the young being favoured over the elderly might simply 
be a reflection of the general public’s preference for a person’s capacity to benefit. 
Another eight studies suggest that preferences for age display an inverted U pattern, implying 
a person at working age is valued most (Baker, et al., 2010; Charny, et al., 1989; Cropper, et 
al., 1994; Diederich, et al., 2012; Jelsma, et al., 2002; Palanca-Tan, 2013; Petrou, et al., 2013; 
Whitty, et al., 2014b). Of these, five controlled for the confounding effect of remaining life 
expectancy (Baker, et al., 2010; Charny, et al., 1989; Jelsma, et al., 2002; Palanca-Tan, 2013; 
Petrou, et al., 2013) while the other three did not.  
Discordant evidence comes from the remaining three studies. Diederich, et al. (2011) reported 
that age had little effect on health care priority setting while Linley and Hughes (2013) 
suggested that children were not favoured over adults. Both studies provided the option of 
equal allocation to different populations which was chosen by the majority of respondents. 
Lancsar, et al. (2011) found that age at onset and age at death if untreated had little effect and 
a very small effect respectively. This could be due to the fact that, unlike the majority of studies 
in the review, respondents were able to trade-off age against the size of the health gain and the 
resulting preference for the size of the health gain outweighed the preference for age. Both 
Linley and Hughes (2013) and Lancsar, et al. (2011) controlled for the confounding effect of 
remaining life expectancy while Diederich, et al. (2011) did not. 
In total 15 studies controlled for the confounding effect of remaining life expectancy through 
four approaches: (1) four studies explicitly assumed the remaining life expectancy from current 
age is the same (Dolan and Tsuchiya, 2005; Johri, et al., 2009; Nord, et al., 1996; Olsen, 2013); 
(2) four studies used wordings such as “all else being equal” (Charny, et al., 1989; Lewis and 
Charny, 1989; Linley and Hughes, 2013; Palanca-Tan, 2013); (3) two considered age and the 
remaining life expectancy simultaneously (Lancsar, et al., 2011; Schwappach and Strasmann, 
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2006); while (4) five studies explicitly stated in the survey that the preference is about a fixed 
number of  years of life in full health (or a given quality of life (QoL)) at different ages (Baker, 
et al., 2010; Dolan and Tsuchiya, 2012; Jelsma, et al., 2002; Petrou, et al., 2013; Tsuchiya, et 
al., 2003).The remaining 10 studies did not control for the confounding effect of remaining life 
expectancy. Whether the preferences elicited in these studies are about age per se or about 
remaining life expectancy will depend on how respondents interpreted the question context and 
the assumptions they made..  
Severity 
Severity is included as a characteristic of the beneficiary since severity of an illness is 
experienced by the patient. Nineteen studies (30%) elicited preferences for severity. There is 
considerable heterogeneity in the definitions of severity used in the literature. Table 3 
documents the use of three types of severity related attributes. Not all 19 studies explicitly 
defined these attributes as severity but all three types have been explicitly defined as severity 
in the literature. The most popular definition is based on ‘QoL if untreated’. Four studies also 
defined severity in terms of life expectancy (LE) if untreated (or age of onset and age of death 
if untreated) (Dolan and Tsuchiya, 2005; Lancsar, et al., 2011; Lim, et al., 2012; Whitty, et al., 
2011). A number of studies loosely referred to pre-treatment health problems but did not 
describe the specific problems (Dolan and Shaw, 2003; Green, 2009; Green and Gerard, 2009; 
Linley and Hughes, 2013; Ryynanen, et al., 1996; Ubel, 1999; Winkelhage and Diederich, 
2012).   
[INSERT TABLE 3] 
Nevertheless, the empirical evidence is consistent with 19 (out of 22) studies suggesting that 
members of the general public are in general willing to give priority to a patient with more 
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severe disease. Among these studies, three further highlight that severity may be one of the 
most important attributes to use in health care priority setting: Dolan and Shaw (2003) and  
Diederich, et al. (2012) both ranked severity as the most important attribute and Linley and 
Hughes (2013) reported that ‘more severely ill’ was favoured regardless of size of health gain 
or cost of treatment.  
Discordant evidence comes from the remaining three studies. Dolan and Tsuchiya (2005) and 
Lancsar, et al. (2011) found small or no effects of severity on priority setting with the small 
effect favouring the less severely ill. In the former, preference for severity is outweighed by 
the preference for the size of the health gain; in the latter respondents may be quite divided 
between favouring severe and less severe conditions, along with indifferent respondents.  Ubel 
(1999) found that preferences for prioritising more severely ill patients were sensitive to the 
question framing.  
Lifestyle/Self-induced illness 
Ten studies (16%) elicited preferences for lifestyle or self-induced illness. All suggest that the 
general public would give less priority to those considered in some way responsible for their 
ill health. However,  Edlin, et al. (2012) found that this preference against self-induced illness 
was outweighed by the preference for prioritising the more severely ill. 
Socioeconomic status (SES) 
Ten studies (16%) elicited preferences relating to beneficiaries’ SES. Eight suggest that 
respondents tend to favour individuals with low SES over those with high SES. The other two 




Other attributes of beneficiaries 
Other attributes were explored by a relatively small number of studies, including  having 
dependents, marital status, employment status, gender, indigenous people, QoL after treatment, 
treatment potential, rarity of disease, lifetime QALYs (i.e., health from a specific time to death), 
past QALYs (i.e., health experienced up to now), and past QoL  (i.e., QoL of all the past years). 
Results are summarised in Supplementary Appendix 3. 
3.3.2. Characteristics of health gain 
Size/distribution of the health gain 
Twenty three studies (36%) elicited preferences for size or distribution of the health gain. Again 
there is heterogeneity in the definition of health gain used in the literature including: gain in 
life years; QoL; and QALYs. If QoL is fixed, gain in life years would imply gain in QALYs. 
However, when using gain in life years, studies in general did not assume QoL to be fixed. 
Larger gains are universally preferred over smaller gains and size of health gain was considered 
one of the most important attributes for health care priority setting in 3 studies (Dolan and Shaw, 
2003; Lancsar, et al., 2011; Linley and Hughes, 2013). 
Four studies suggest that the preference for larger gains may diminish as the size of gain 
increases (Lancsar, et al., 2011; Nord, et al., 1996; Norman, et al., 2013; Richardson, et al., 
2011). This is in line with the finding of another six studies which suggest that  people prefer 
to give small gains to many rather than large gains to a few (Gyrd-Hansen and Kristiansen, 
2008; Olsen, 2000; Richardson, et al., 2012; Ubel, et al., 2001; Ubel, et al., 2000; Ubel, et al., 
1996). However, Gyrd-Hansen and Kristiansen (2008) and Olsen (2000) found this preference 
for dispersion of gain over concentration happens only when the gain per person is greater than 
a certain threshold.  
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Prevention vs. cure  
Five studies (8%) elicited preferences between prevention and cure. The majority suggest that 
prevention is preferred; the exception being Corso, et al. (2002) who found that cure was 
favoured over prevention based on median WTP estimates. During preference elicitation, all 
five studies kept the size of the health gain constant and all but Corso, et al. (2002) kept costs 
constant. However, WTP studies generally do not consider the costs of treatments. This may 
explain Corso, et al. (2002)’s unexpected result as some respondents may have thought cure is 
more costly than prevention and therefore were willing to pay more for an expensive good than 
for a cheap good. 
Components of health gain 
Five studies (8%) elicited preferences for different components of health gain. Three 
components have been identified from the literature including the gain from QoL enhancement, 
from life extension, and from lifesaving (prevention of premature death). Results overall 
generally suggest gain from life extension is favoured over the gain from QoL enhancement 
(Olsen and Donaldson, 1998; Pennington, et al., 2013; Whitty, et al., 2014b). However, this 
preference may not apply to all life stages, e.g., at the very end of life, the gain from QoL 
improvement becomes more valuable than the gain from life extension (Pinto-Prades, et al., 
2014; Shah, et al., 2014). Finally, Olsen and Donaldson (1998) showed that a lifesaving gain 
was valued much more highly than the other two types of health gain. Among the five studies, 
all but Whitty, et al. (2014b) fixed the size of the health gain, but none fixed the costs of 
treatments. Again, three were WTP studies which in general do not consider costs of treatments.  
Other health gain attributes 
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Two further attributes related to the characteristics of health gain have been explored: the 
timing of saving lives with Cropper, et al. (1994) finding people attach less importance to 
saving lives in the future than the present, and geographic equality of health gain distribution 
which was favoured by the respondents in a study by Quintal (2009).  
3.3.3. Other important contextual factors 
Cost of treatment 
Eight studies (13%) elicited preferences for the cost of treatment. The majority (five studies) 
suggest a preference for lower cost. However, two studies found higher cost was preferred 
(Linley and Hughes, 2013; Ryynanen, et al., 1996) and one found cost had little effect (Nord, 
et al., 1995). Plausible explanations have been offered for this surprising result: Ryynanen, et 
al. (1996) stated that respondents potentially associated expensive care with severe disease 
while Linley and Hughes (2013) suspected that the elicited preference related to a general 
preference for fairness in receiving treatment based on need. All but Ryynanen, et al. (1996) 
and  Nord, et al. (1995) fixed the size of the health gain. 
Other contextual attributes 
Several other contextual factors were explored by a small number of studies. These include 
availability of alternative treatment, number of patients, chance of success, cost effectiveness, 
and uncertainty in evidence. Results are included in Supplementary Appendix 3.  
3.3.4. Cross-cutting attribute: end of life treatment 
End of life treatment is defined by the National Institute for Health and Care Excellence (NICE) 
as a treatment that meets three criteria based on life expectancy if untreated (less than 24 
months), life expectancy gain from treatment (at least 3 months), and the size of patient 
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population (small population) (National Institute for Health and Clinical Excellence, 2009).  
We single it out as a cross-cutting attribute since these criteria correspond to all three types of 
attributes: severity, size of health gain, and number of beneficiaries. Seven studies (11%) 
elicited preferences for end of life treatment which, in most cases, has been defined using only 
the first two criteria. Evidence is mixed: five studies provide weak or no support for favouring 
such treatment while the other two suggest moderate support (Pennington, et al., 2013; Pinto-
Prades, et al., 2014).  
3.4. Methods for elicitation of distributional weights 
Among those using samples drawn from the general public, only 22 studies (34%) calculated 
distributional weights. Methods used to calculate relative weights included: PTO, DCE and 
social welfare function (SWF) based methods. Table 4 documents the 22 studies classified by 
methods and attributes. 
[INSERT TABLE 4] 
PTO was used in 15 studies. PTO asks respondents how many outcomes of one kind (condition 
A) are equivalent in social value to X outcomes of another kind (condition B). If one person’s 
answer is Y, then this individual’s weight between condition A and B are X/Y and 1. Typically 
individual responses have been aggregated in two ways: the ratio of means (or medians); or the 
mean (or median) of the ratios (Baker, et al., 2010).  
Five studies used the SWF based approach. Typically a certain type of SWF needs to be chosen, 
and then its parameters are assumed and/or estimated through a bespoke choice exercise (a 
factorial experimental design is typically not involved except in Palanca-Tan (2013)) which 
usually involves multiple groups of patients at different levels of one attribute (e.g., age, 
severity, social class) and with different aggregate health. The distributional weights for the 
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attribute are estimated as the marginal rate of substitution between groups (Dolan and Tsuchiya, 
2011). 
Two studies derived weights using DCEs. Lancsar, et al. (2011) introduced a method based on 
the compensating variation to derive weights. In their study, two types of distributional weights 
were calculated: (1) weights for different levels of individual attributes and (2) weights for 
different combinations of attributes. Using the same DCE data, Baker, et al. (2010) also 
presented an approach called ‘predicted probability of choice’. It produced somewhat larger 
weights compared to the compensating variation based approach. Finally, Norman, et al. (2013) 
used the marginal rate of substitution, to calculate weights for different combinations of 
attributes. 
3.5. Distributional weights 
Most distributional weights were elicited for age (11/22 studies that elicited weights) and 
severity (4/22 studies that elicited weights). These results are discussed here. Results for 
attributes other than age and severity are documented in Supplementary Appendix 2. 
Age 
Since the methods, attribute levels and question framings vary from study to study, it is 
challenging to synthesise and compare the distributional weights estimated from these studies. 
Nevertheless, the smallest weights are reported from a study using a DCE. In Lancsar, et al. 
(2011), the weights for age of onset were all close to 1, implying no weighting. Such weights 
are calculated by changing age of onset from its reference level of 40 years, while holding all 
other variables at their reference level (QoL lost=0.7, age of death=60 and QALY gain=4). 
While the authors do not state this in their paper, given they control for the confounding effect 
of remaining life expectancy, this suggests the elicited weights can be interpreted as weights 
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for age per se. For age of death without treatment, higher weight was given to those who die 
young, aged 10, or die old, aged 70 or 80, although the weights remained relatively small.  In 
contrast, the largest weights are reported from a study using PTO. In Johannesson and 
Johansson (1996), saving one person at age 30 was equivalent to saving 35 people at age 70, 
implying a weight of 35 to 1 between age 30 and 70. Apart from using different samples and 
sample sizes, there are two reasons that may explain this drastic difference. First, in Lancsar, 
et al. (2011) health gain is another attribute considered along with age and the analysis suggests 
that the choices were driven by the size of the health gain. Second, Johannesson and Johansson 
(1996) used a lifesaving context and did not explicitly fix the remaining life expectancy for 
patients of different ages. As previously discussed, respondents may conflate preferences for 
age per se and preferences for the remaining life expectancy in which case weights are more 
likely to represent the value of the remaining life expectancy from different ages rather than 
the value of one year in full health at different ages. Evidence suggests that the former may 
lead to larger weights favouring the young over the elderly than the latter (Jelsma, et al., 2002).  
Severity 
Compared to age weighting, an additional challenge to synthesise distributional weights for 
severity is that there is considerable heterogeneity in the definitions of severity used in the 
literature. Nevertheless, the smallest weights again come from a DCE study where significantly 
less weight (although still relatively close to 1) was given to the relatively more severe (Lancsar, 
et al., 2011). The largest weights are from a PTO study where saving one life was equivalent 
to returning 3 patients with severe health problems to full health (Nord, et al., 1993). The 
implied weights are 3 to 1 between saving a life and returning someone severely ill to full 
health.  
4. Discussions and conclusions 
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This review has highlighted a large and increasing literature spanning five continents 
suggesting that the topic of preferences in relation to health care priority setting is highly 
relevant from an academic and policy perspective. 
Empirical evidence has mainly focused on the characteristics of the recipients of health care 
and within this a particular focus on age and severity. Results generally suggest that the young 
are favoured over the old and the more severely ill are favoured over the less severely ill. There 
is evidence to suggest that people with self-induced illness or high SES should receive lower 
priority. Larger health gain is universally preferred, but potentially at a diminishing rate. These 
results are in general consistent with findings of past reviews. We also identified attributes that 
have previously been less explored. For example, a small number of studies suggest that life 
extension is favoured over QoL enhancement, although this preference may be reversed at the 
end of life. Also, our review suggests that, while in some jurisdictions higher weight is given 
to end of life treatment (National Institute for Health and Clinical Excellence, 2009), the 
majority of studies that investigated end of life care found weak/no support for providing a 
premium for such care.  
This review is the first effort in the literature to review studies exploring distributional weights 
across a range of attributes. While 64 papers explored the broad topic of preferences for health 
care priority setting, only 34% calculated distributional weights. Where weights were derived 
they generally focused on age and severity, despite evidence in this review that other 
characteristics of recipients of the health gain may be important as may the characteristics of 
the health gain itself or other contextual factors. Deriving weights for a broader set of 
characteristics would be a natural extension warranting further research. The variation in the 
magnitude of the distributional weights reported in the literature is very large, likely due to 
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large heterogeneity in methods, contexts, countries/populations, sample sizes and the particular 
attributes (and their definitions) considered in the studies.   
Eight different preference elicitation methods were used in the literature included in this review. 
There has been little consistency in methods although the majority of studies used a choice 
based approach with PTO and DCE being the most popular. Earlier in the literature PTO was 
the method most likely to be used but the more recent literature appears to be moving 
increasingly to using DCEs. DCEs have mainly been used to elicit preferences (usually 
investigated by examination of direction and significance of parameters estimated in the choice 
model). However, very few DCEs went on to derive distributional weights from the estimated 
choice models possibly because there has not been a standard method to derive weights. This 
would be a fruitful avenue for further research. In contrast, PTOs involve the direct elicitation 
of weights from which preferences are inferred. PTOs generally produced much larger 
distributional weights than DCEs. The focus in PTOs on single attributes one at a time rather 
than allowing trade-offs over multiple attributes could artificially inflate the resulting relative 
weights compared to DCEs which involve tradeoffs across multiple attributes simultaneously 
(Lancsar, et al., 2011). Similar results suggesting some strong isolated effects disappeared after 
the effects of additional attributes were taken into account were found by others using non-
DCE and non-PTO methods (Edlin, et al., 2012; Linley and Hughes, 2013). However, this 
remains an unresolved issue. In light of the extreme differences in empirical results found from 
DCE and PTOs, sometimes even within the same study populations (Baker, et al., 2010), future 
work on theoretical and empirical reconciliation is important to ascertain the extent to which 




While using different methods may explain a large part of the variation in the estimated 
distributional weights, substantial differences also exist among studies using the same approach. 
One possible reason is that, while these studies derive weights for similar attributes, there is 
heterogeneity in the definitions of these attributes. In the case of age weighting, there is a 
distinction between value of a year of life at different ages and value of the remaining life from 
different ages. The latter may lead to larger weights between young and old. Similarly, severity 
is the attribute with the least consensus regarding its definition and description to respondents. 
Regarding health gain, despite the literature often being couched in terms of distributional 
weights for QALYs, few studies defined the health gain attribute in terms of QALYs. Future 
consistency in terms of attribute descriptions may be warranted but should be balanced against 
the need to define attributes such that they allow investigation of the research questions at hand 
within each study.  Another possible reason for the wide variation in weights is that even within 
the same approach, the method used to calculate weights can differ. For example, within DCE, 
based on very limited evidence, it seems the compensating variation, predicted probability and 
the marginal rate of substitution approaches may lead to different results.  
A number of areas would benefit from future research. One is interactions between attributes 
and their effect on preferences for priority setting and distributional weights. Given the 
complex and multifaceted nature of priority setting, it may be that preferences for one attribute 
are influenced by preferences for another. For example, does the size of the health gain affect 
preferences for prioritising across severity? Interactions were rarely considered in the literature 
covered in this review (with two exceptions: Whitty, et al. (2014b) and Norman, et al. (2013) 
but are an important area warranting further research to uncover potentially important nuances 
in preferences and weights.  
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A large subset of papers included in the review loosely refer to social value and social 
preferences. While such studies generally did not provide explicit definitions (an exception is 
Gyrd-Hansen & Kristiansen, 2008), they loosely refer to social values or social preferences 
(and trade-offs between equity and efficiency) to distinguish such studies from individual 
preference based studies. When being asked to consider resource allocation within a publicly-
funded system, studies that referred to social preferences and values generally asked 
respondents to think about community (with or without themselves being included in that 
group), whereas studies eliciting individual preferences involved respondents thinking only 
about themselves. It is not surprising that concepts of social value and preferences have not 
been well defined in the studies in this review given the debate in the literature more generally 
regarding social choice theory (Arrow, et al., 2010). However, future research in this area 
would benefit from defining such concepts more explicitly, at least in the context of study 
objectives and the interpretation of results. 
A related issue is the perspective used for preference elicitation in the context of health care 
priority setting at a government level. Framing of perspectives used was generally poorly 
expressed and in some circumstances inconsistent with the choice context described to 
respondents. As for the personal, impartial decision making or citizen, ex post or ex ante, which 
to use will largely depend on a study’s specific objective (Dolan, et al., 2003). Nevertheless, 
researchers are encouraged to distinguish these perspectives and to provide justification for 
their choices. Further research comparing the preferences and weights elicited from different 
perspectives is also warranted.  
While important work has been undertaken to provide information on the general public’s 
preferences in relation to health care priority setting, this review has highlighted a large degree 
of variation in both methods and empirical results. The literature seems to have converged 
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towards DCE as a dominant approach to deriving preferences for priority setting in this area. 
However, the calculation of weights within DCE is in its infancy but represents a fruitful area 
for further research. Within this and other methods, it is important to account for the 
methodological issues noted above. Such methodological work would assist in achieving the 
goal of deriving robust distributional weights that could assist policy makers faced with the 
important challenge of prioritising the allocation of scarce health care resources.   
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Table 1 Inclusion and exclusion criteria for the literature review 
  Inclusion criteria Exclusion criteria 
Language - English - Not in English 
Publication - Peer reviewed - Not peer reviewed 
Context 
- Stated preferences 
- Health care setting 
- Include competing criteria, 
interventions, or patients in a 
general setting 
- Applicable to priority setting for 
publically-funded health care 
- Revealed preferences  
- Non health care setting 
- Criteria, interventions, or patients in a 
specific setting (e.g. HIV/AIDS, 
organ transplantation, informal/formal 
services)  
- Broad or narrow priority setting level 
(e.g. global priorities, priorities within 
a healthcare facility) 
Data - Empirical studies - Other studies (e.g. theoretical studies, editorials, review articles) 
Methods 
- Quantitative methods for trade-
offs (e.g. choice-based methods, 
person trade-off methods, and 
ranking or rating exercises). 
- Qualitative methods (e.g. focus 
groups and structured interviews, 
percentage agreement with a 
statement).  
Sample - General public 
- Subgroups of the general public (e.g. 
patients, clinicians, gender, specific 
age) 










Table 2 Attributes explored in each study 
Study Age Severity Lifestyle/Self-induced illness SES 






















                        
 Baker, et al. 
(2010)                         
 Bleichrodt, et 
al. (2005)         Lifetime QALYs                
Bosworth, et 
al. (2010)                          
 Bryan, et al. 
(2002)          QoL after treatment           
Number of patients, 
Chance of success    
 Charny, et al. 
(1989)         
 Marital status, 
Employment status, 
Gender 
              
 Corso, et al. 
(2002)                         
 Cropper, et 
al. (1994)                 
Timing of saving 
lives        
Diederich, et 
al. (2012)          
Having dependents, 
Marital status               
Diederich, et 
al. (2011)                          
Dolan and 
Shaw (2003)           Having dependents                
 Dolan and 
Tsuchiya 
(2005) 
        Past QoL                
 Dolan and 
Tsuchiya 
(2009) 
                        
 Dolan and 
Tsuchiya 
(2011) 
                        
 Dolan and 
Tsuchiya 
(2012) 
         Past QALYs               
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Study Age Severity Lifestyle/Self-induced illness SES 














attributes End of life 
 Edlin, et al. 
(2012)         Lifetime QALYs                
Eisenberg, et 
al. (2011)                          




                    
Availability of 
alternative treatment, 
Cost effectiveness  
  
Gyrd-Hansen 





                         
 Jelsma, et al. 








                        
Johri, et al. 
(2009)                          
Lancsar, et al. 




                        
 Lim, et al. 




        Having dependents, Rarity of disease              
Availability of 
alternative treatment     
Mortimer and 
Segal (2008)                        Uncertainty in evidence   
Nord, et al. 
(1993)                          
Nord, et al. 
(1995)                           
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Study Age Severity Lifestyle/Self-induced illness SES 














attributes End of life 
Nord, et al. 
(1996)                          
 Norman, et 
al. (2013)          Having dependents                
Olsen (2000)                          
 Olsen (2013)                         
 Olsen and 
Donaldson 
(1998) 
                        
Palanca-Tan 
(2013)                      Number of patients     
Pennington, et 
al. (2013)                          
Petrou, et al. 
(2013)                          
 Pinto-Prades, 
et al. (2014)                         
Quintal 
(2009)                  
Geographic 
equality        
 Richardson, 
et al. (2012)                          
 Richardson, 
et al. (2011)                         
 Roberts, et al. 
(1999)         QoL after treatment                
Ryynanen, et 
al. (1996)                           
 Schwappach 





         Rarity of disease                
 Shah, et al. 
(2014)                         
Shiroiwa, et 
al. (2013)                          
Singh, et al. 
(2012)                          
Tsuchiya and 
Dolan (2007)                          
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Study Age Severity Lifestyle/Self-induced illness SES 














attributes End of life 
Tsuchiya, et 
al. (2003)                          
 Ubel (1999)                         
 Ubel, et al. 
(2001)                         
 Ubel, et al. 
(2000)                         
 Ubel, et al. 
(1996)                         
Ubel, et al. 
(1999)           Treatment potential               
 Ubel, et al. 
(1997)                         
Whitty, et al. 
(2014a)          Indigenous people            
 Availability of 
alternative treatment, 
Number of patients, Cost 
effectiveness    
  
Whitty, et al. 
(2008)          QoL after treatment             Chance of success     
Whitty, et al. 




                         
 
Note: 
(1) SES: socioeconomic status  






Table 3 Descriptions of severity and frequency of use 
Severity description Frequency Percentage 
QoL(1) if untreated or QoL loss if untreated (i.e., 1- QoL if 
untreated) 12 52 
Pre-treatment health problems, not clearly defined 7 30 
LE if untreated(2) 4 17 
Total 23 100 
  
Note:   
(1) QoL means ‘quality of life’.  
(2) LE means ‘life expectancy’; Lancsar, et al. (2011) included LE implicitly via age of onset and age 
of death. 
(3) Several studies used more than one severity related attributes so the frequency of use here adds up 



















Table 4 Distributional weights classified by attributes and methods 
Study 
Age Severity Other attributes 
PTO DCE SWF PTO DCE SWF PTO DCE SWF 
Baker, et al. (2010)                    
Cropper, et al. (1994)                    
Eisenberg, et al. (2011)                    
Jelsma, et al. (2002)                    
Johannesson and Johansson (1996)                   
Johannesson and Johansson (1997)                   
Nord, et al. (1993)                    
Nord, et al. (1996)                   
Petrou, et al. (2013)                    
Pinto-Prades, et al. (2014)              End of life      
Quintal (2009)             Geographic equality of health gain distribution      
Richardson, et al. (2011)                    
Schwappach (2002b)              Prevention vs cure      
Singh, et al. (2012)              Lifestyle      
Ubel, et al. (1999)              Treatment potential      
Bleichrodt, et al. (2005)                  Lifetime QALYs  
Dolan and Tsuchiya (2009)                  Self-induced illness  
Dolan and Tsuchiya (2011)                   SES 
Dolan and Tsuchiya (2012)                 Past QALYs  
Palanca-Tan (2013)                  
Lancsar, et al. (2011)                 Combination of several attributes including health gain   
Norman, et al. (2013)        Combination of several attributes including health gain  
Note: (1) PTO: Person trade-off ; (2) DCE: Discrete choice experiment; (3) SWF: Social welfare function; (4) SES: Socioeconomic status 
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Results to August 13, 2014 (n=4,461) 
 
MEDLINE (n=2383); EMBASE (n=1219); 









Results to August 22, 2014 (n=43) 
Full-text studies assessed for eligibility 
(n=236) 
 
Studies included for the review (n=64) 
Studies excluded (n=172) 
 
Not in English (n=3) 
Not peer reviewed (n=14) 
Not the right context (n=48) 
Not empirical (n=37) 
Not the right method (n=23) 










Records excluded (n=3,057) 
Duplicates removed (n=1,211) 















































(1) Studies using simple choice exercise present respondents with scenarios that vary with respect to one attribute, and ask them to choose or allocate points between them. This category 
includes studies where the dependent variable is discrete choice or allocation of points. 
(2) Studies using choice exercise with bespoke design typically involve multiple attributes and are designed to address specific hypotheses or theories without the use of a factorial experimental 
design.  
(3) Simple ranking exercise ranks a list of attributes based on their relative importance.  
(4) Frequency of use for each method is recorded in brackets. Whitty, et al. (2014b) used both DCE and BWS, and Pinto-Prades, et al. (2014) used both PTO and CVM. Hence, the numbers add 


































points   (n=1) 
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Appendix 1 Complete search strategy 
 
Database: Ovid MEDLINE, searched on 13 Aug, 2014 
 Database Ovid MEDLINE(R) 1946 to Present with Daily Update 
Search No Searches Results 
1 exp resource allocation/ or exp health care rationing/ 15526 
2 exp Health Priorities/ 8892 
3 (health care or healthcare).ti,ab. 295660 
4 (resource$ adj5 allocation).ti,ab. 7424 
5 (priorit$ adj5 set$).ti,ab. 3289 
6 3 and 4 2196 
7 3 and 5 927 
8 exp Technology Assessment, Biomedical/ 9262 
9 (health technolog$ adj5 assessment$).ti,ab. 1880 
10 exp Drug Approval/ec, mt [Economics, Methods] 1055 
11 (reimbursement adj5 decision$).ti,ab. 430 
12 (coverage adj5 decision$).ti,ab. 525 
13 (public insurance adj5 coverage$).ti,ab. 57 
14 cost effectiveness threshold$.ti,ab. 253 
15 1 or 2 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 36876 
16 preference$.ti,ab. 88016 
17 relative importance.ti,ab. 12932 
18 (tradeoff$ or trade off$).ti,ab. 12549 
19 league table$.ti,ab. 228 
20 (multi-criteria or multiple-criteria) .ti,ab. 832 
2 
 
21 exp Social Values/ 18989 
22 social value$.ti,ab. 917 
23 societal value$.ti,ab. 263 
24 distributional weight$.ti,ab. 6 
25 equity weight$.ti,ab. 22 
26 relative weight$.ti,ab.  3102 
27 (QALY$ adj5 maximi$).ti,ab. 41 
28 (health adj5 maximi$).ti,ab. 1087 
29 value for money.ti,ab. 900 
30 
16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 
or 27 or 28 or 29 
136739 
31 15 and 30 2710 
32 limit 31 to humans 2383 
















Database: EMBASE, searched on 13 Aug, 2014 
 Database EMBASE 
Search No Searches Results 
1 'health care' 1181803 
2 'healthcare' 428490 
3 #1 OR #2 1477019 
4 priori* NEAR/5 set* 5104 
5 resource* NEAR/5 allocation 22520 
6 rationing 2793 
7 #3 AND #4 2455 
8 #3 AND #5 13860 
9 #3 AND #6 2337 
10 ‘health technology assessment’ 4847 
11 ‘health technology assessments’ 428 
12 ‘drug approval’ 27653 
13 reimbursement NEAR/5 decision* 957 
14 coverage NEAR/5 decision* 791 
15 'public insurance coverage' 43 
16 'cost effectiveness threshold' 363 
17 'cost effectiveness thresholds' 148 
18 
#7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 
OR #15 OR #16 OR #17 
51774 
19 preference* 123200 
20 ‘relative importance’ 15837 
21 tradeoff* OR ‘trade off’ OR ‘trade offs’ 15922 
22 ‘league table’ OR ‘league tables’ 299 
4 
 
23 'multi-criteria' OR 'multiple-criteria' 1322 
24 'social value' OR 'social values' 1214 
25 'societal value' OR 'societal values' 363 
26 'distributional weight' OR 'distributional weights' 8 
27 'equity weight' OR 'equity weights' 18 
28 'relative weight' OR 'relative weights' 3606 
29 qaly* NEAR/5 maximi* 65 
30 health NEAR/5 maximi* 1814 
31 'value for money' 1342 
32 
#19 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR 
#26 OR #27 OR #28 OR #29 OR #30 OR #31 
161893 
33 #18 AND #32 1647 
34 #33 AND [humans]/lim 1219 















Database: ECONLIT, searched on 13 Aug, 2014 
 Database Econlit (via EBSCOhost) 
Search syntax 
( ( ("health care" OR healthcare) AND (priorit* N5 set* OR resource* N5 
allocation OR rationing) ) OR ( health technolog* N5 assessment* OR drug* N5 
approval OR reimbursement N5 decision* OR coverage N5 decision* OR "public 
insurance coverage" OR "cost effectiveness threshold*" ) ) AND ( preference* OR 
"relative importance" OR tradeoff* OR "trade off*" OR "league table*" OR 
"multi-criteria" OR "multiple-criteria" OR "social value*" OR "societal value*" 
OR "distributional weight*" OR "equity weight*" OR "relative weight*" OR 
QALY* N5 maximi* OR health N5 maximi* OR “value for money” ) 






















Database: WEB OF SCIENCE (SCI-EXPANDED & SSCI), searched on 13 
Aug, 2014 
 Database WEB OF SCIENCE 
Search No Searches Results 
1 TS=(healthcare OR "health care") 255941 
2  TS=(priorit* NEAR/5 set*) 5256 
3 TS=(resource* NEAR/5 allocation) 23089 
4 TS=(rationing) 22299 
5 #4 OR #3 OR #2 49932 
6 #5 AND #1 3988 
7 TS=("health technology assessment*") 1905 
8 TS=("drug approval") 806 
9 TS=(reimbursement NEAR/5 decision*) 486 
10 TS=(coverage NEAR/5 decision*) 725 
11 TS=("public insurance coverage" ) 37 
12 TS=("cost effectiveness threshold*") 251 
13 #12 OR #11 OR #10 OR #9 OR #8 OR #7 OR #6 7846 
14 TS=(preference*) 199455 
15 TS=("relative importance" ) 31097 
16 TS=(tradeoff* OR "trade off*") 61920 
17 TS=("league table*") 540 
18 TS=("multi-criteria" OR "multiple-criteria") 8210 
19 TS=("social value*" OR "societal value*" ) 3527 
20 TS=( "distributional weight*" OR "equity weight*" OR "relative weight*") 5101 
21 TS=(QALY* NEAR/5 maximi* ) 43 
7 
 
22 TS=(health NEAR/5 maximi* ) 1082 
23 TS=(“value for money”) 1255 
24 #23 OR #22 OR #21 OR #20 OR #19 OR #18 OR #17 OR #16 OR #15 OR #14 304024 
25 #24 AND #13 732 




Appendix 2 Summary of included studies 










/ ex post 
choice exercise with 
bespoke design 









maker / ex 
post 
choice exercise with 
bespoke design 
social class: low > high  





England population  
Social 
non-specific 
/ ex post 
PTO (DCE is the same 
as Lancsar et al. 
(2011)) 
(1) age: overall the young are favored over 
the old; 20-40 years > 40-60 years> 0-20 
years > 60-80 years 
(2) severity: not the most severe condition 
gets priority; instead, it is ranked among the 
lowest 
 
Using the ‘ratio of mean’ method: 
age weights(average over severity) 
for 0-20, 20-40, 40-60, 60-80 years 
are 0.775, 1, 0.814, 0.527 
severity weights (average over age) 
for 0->20%, 20%->40%, 
40%->60%, 60%->80%, 









179 respondents from 
the Dutch population 
Impartial 
decision 
maker / ex 
post 
 
choice exercise with 
bespoke design; 
weights estimated 
using the social welfare 
function based method 
 
expected lifetime QALYs: a new born with 
smaller lifetime QALYs is favored over a 
new born with larger lifetime QALYs 
reported for different number of 
expected lifetime QALYs (see table 




1500 respondents each 





/ ex post 
DCE 
 
(1) number of illnesses prevented or number 
of recoveries increased: its marginal utility 
from prevention policies is the same as the 
one from treatment policies 
(2) number of deaths avoided: its marginal 
utility from prevention policies is about 
twice as much as the one from treatment 
policies 




Bryan et al. 
(2002) 
UK 
909 respondents from 
Hertfordshire, highly 




/ ex post 
DCE 
 
(1) number of people 
(2) chance of success  
(3) LE after treatment 
(4) QOL after treatment 




Charny et al. 
(1989) 
UK 
a random sample of 




/ ex post 
simple choice exercise 
(1) age: young children are less valuable 
than older children, but elderly people are 
less valued than young people 
(2) lifestyle/culpability: healthy > not 
healthy, inherited disease > self-induced 
disease 
(3) social class: no effect (significant 
minority prefers a director over a person 
without skills, a teacher over a lorry driver) 
(4) employment status: no effect (significant 
minority prefers employed over 
unemployed) 
(5) gender: no effect (significant minority 
prefer female over male) 
(6) marital status: married > single 
  





Personal / ex 
post 
CVM 
prevention vs treatment: the former's WTP is 





1000 households in 
Maryland (Maryland 
Poll), 564 households 
in the Washington D.C. 
metropolitan area, and 




/ ex post 
PTO 
(1) timing of health gain: today > future 
(2) age: the young are favoured over the old 
with a peak of age-related preference for 
patients aged around 28 
For the median respondent, the 
weights for life saving in 100 years, 
in 25 years, and today are 1/45, 1/6, 
and 1; the weights for life saving at 
20, 30, 40, and 60 years old are 8, 












/ ex post 
simple choice exercise 
(DCE is the same as 
Diederich et al. (2012)) 
age: little evidence that the German public 
accepts age as a criterion to prioritize health 







representative of the 




/ ex post 
DCE 
Mean preferences: 
(1) health status: severe disease > light 
disease 
(2) quality of life: severely restricted > 
restricted > no restrictions 
(3) unhealthy life style: yes > no 
(4) age of patient: 43 > 25 > 68 >87 
(5) family status: single with dependents > 
single without dependents >= couple with 
dependents > couple without dependents 
(6) occupational status: low > medium > 
high  
Relative importance: 
(1) health status ( 50%) 
(2) quality of life (24.7%) 
(3) age (12%) 
(4) family status (7.9%) 
(5) occupational status (4.6%) 







a representative sample 
of 23 from York 
Social 
non-specific 
/ ex post 
simple ranking exercise 
no-treatment profile > health gain > time 
spent waiting for treatment > lifestyle 
choices > previous health profile > impact 












/ ex post 
ranking exercise with 
experimental design 
 
(1) age: 40 > 60 
(2) severity: mixed results based on different 
severity measures: 
past health (QOL without condition): mixed 
- it had a significant effect in the context of 
imminence of death, but was not significant 
in the context of severity of health 
future LE without treatment: statistically 
insignificant 
future QOL without treatment: statistically 
insignificant 







a random sample of 




/ ex post 
choice exercise with 
bespoke design; 
weights estimated 
using the social welfare 
function based method 
self-induced/unhealthy lifestyle: significant 
negative 
respondents wanted to give people 
who have not cared for their own 
health about half as much weight as 








130 respondents from 
York, broadly 
representative for the 




/ ex post 
choice exercise with 
bespoke design; 
weights estimated 
using the social welfare 
function based method 
(1) SES: low > high 
(2) gender: no effect 
SES: a given health gain in life 
expectancy to the lowest social 
class is weighted (by the median 
respondent) about seven to ten 
times as highly as an equivalent 





600 respondents from 
England, broadly 




/ ex post 
choice exercise with 
bespoke design; 
weights estimated 
using the social welfare 
function based method 
age and health profile before treatment: 
value of health gain is larger for young 
people whose QOL is low 
Reported in Table 1 of Dolan and 
Tsuchiya (2012), e.g., the general 
public value extra 1 year in full 
health for a 50-year-old who is 
otherwise about to die as about the 
same as extra 10 years in full health 
for a 70-year-old who is otherwise 
about to die. 
Edlin et al. 
(2012) 
UK 
a sample of 559 
respondents broadly 




/ ex post 
choice exercise with 
bespoke design 
(1) lifetime health: the poorer are favoured 
(2) self-induced illness: disfavoured but its 












/ ex post 
PTO age: the young are favored over the old 
the weights for age 10 and 60 are 






261 respondents from 
Southampton City 
Council, broadly 




/ ex post 
choice exercise with 
bespoke design 
(1) Severity: In the severity of health 
question 60% indicated that a unit of health 
gain in a severely affected patient group was 
of greater social value to that same unit of 
health gain in a moderately affected patient 
group, all else equal.  
(2) SES: When described by level of 
disadvantage, 80% of respondents stated 
such a preference, which indicates that they 
attach a greater social value to a unit of 
health gain in a disadvantaged patient group, 












maker / ex 
ante 
DCE 
(1) the average health improvement 
expected from the treatment: large > 
moderate> small> very small 
(2) cost-effectiveness of treatment – the 
value for money expected from the 
treatment: very good > fairly good > fairly 
poor > very poor 
(3) severity: yes > no 








a random sample of 




/ ex post 
DCE 
QOL(measured using EQ-5D health states) 
before and after treatment: patients in a more 
severe health state are favoured provided 
their expected benefits are large enough to 
bring them to the health level where their 
rival patients are without treatment - this 
equity concern was more significant on 
specific health dimensions such as 









a random sample of 




/ ex ante 
DCE 
Distribution of fixed gain: In the context of 
life-saving, it shows there are preferences 
for both spreading and concentration of 
health gains. Respondents also adopt 
thresholds when they value treatment offers 
(spreading is preferred if size of gain > 6 
months life expectancy or probability of 
gains > 1/12). This result is consistent 




Jelsma et al. 
(2002) 
Zimbabwe 
a random sample of 67 
respondents from a 




/ ex post 
PTO 
age: the young are favored over the old, and 
15 is the most highly valued age 
The mean weights for 1, 15, 30, 45, 
and 75 years are  
(1) 1.76, 2.19, 1, 0.76, and 0.33 
(when gain is stated as lifesaving) 
(2) 0.95, 1.67, 1, 0.97, and 0.43 
(when gain is stated as sparing one 






a random sample of 




/ ex post 
PTO age: the young are favored over the old 
The weights for life saving at 30, 50 







a random sample of 




/ ex post 
PTO age: the young are favored over the old 
Using parametric estimation, the 
weights for life saving at 30, 50 and 
70 years old are 1, 0.13, and 0.025. 
Using nonparametric estimation, 
the weights for life saving at 30, 50 
and 70 years old are 1.0, 0.2, and 
0.029. 
Johri et al. 
(2009) 
US/Canada 
a sample of 2009 
respondents  from an 
online panel broadly 




maker / ex 
ante 
simple choice exercise: 
allocation of points 
age: people generally prefer allocating 
scarce resources to young patients over older 
ones but  these preferences are significantly 
reduced when participants are encouraged to 





Lim et al. 
(2012) 
South Korea 
716 respondents from 
an internet panel 
broadly representative 
of Korea population 
Not reported DCE 
 
(1) QOL without treatment: low > high  
(2) life years remaining without treatment: 
short > long   
(3) survival gain after treatment: large > 
small  
(4) QOL gain after treatment: high > low  







a random sample of 
587 from the adult 
population in England 
Social 
non-specific 
/ ex post 
DCE; weights 




(1) age at onset: insignificant  
(2) age at death if untreated: significant 
(log-transformed, polynomial) 
(3) QOL if untreated: insignificant (QOL 
loss, log-transformed, polynomial), less 
severe is favoured 
(4) gain in life expectancy 
(5) gain in QOL with treatment 
The last two are combined as QALY gain, 
and participants preferred to treat patients 
who had larger QALY gains, but at a 
diminishing rate. 
end of life (implied): not favored 
 
Weights for individual attribute 
levels (details in Table 4 of Lancsar 
et al. (2011)): 
Age of death without treatment: 
weights for 1,10,20,40,60,70, and 
80 years old are 
1.08,1.16,1.03,1,1.03, and 1.06; 
QOL loss: weights for 0.8, 0.9, 0.7, 
0.4, and 0.1 QOL loss are 0.98, 
0.96, 1, 1.04, and 1.03 
 
Weights for combination of 
multiple attributes (see Table 5 of 







a random sample of 




/ ex post 
simple choice exercise 
age: overall the young are favoured over the 







recruited using an 
online panel, broadly 




/ ex post 
choice exercise with 
bespoke design 
 
(1) health gain: driving the choices, larger 
gain preferred 
(2) costs: driving the choices, higher costs 
preferred  
(3) severity of disease: favoured, regardless 
of health gain and costs 
(4) no alternatives: favoured, even if heath 
gain is little 
(5) innovative treatment: favoured, if health 
gain is substantial 
(6) having dependents (informal carers): 
favoured, with health gain and costs fixed 
(7) children: not favoured 
(8) end-of-life premium: not favoured 
(9) disadvantaged population (e.g., low 
income): not favoured 
(10) rare disease: not favoured 









a random sample of 





(1) self-induced illness: no>yes 
(2) purpose of the intervention: 
prevention>cure 
(3) type of intervention: medical, lifestyle 
(4) number of lives saved per year: the more 
the better (the more effective one is 
favoured) 
(5) quality of evidence: strong>limited 
(6) cost of treatment: less costly is favoured 
(7) contributions from patients: less 
out-of-pocket contribution is favoured 
(8) age/life-stage: young children > young 
adult > working-age adult > older-age retiree 
 
  
Nord et al. 
(1993) 
Norway 
a random sample of 




maker / ex 
ante 
PTO 
severity: more severe health state is valued 
higher 
reported in Table 5 of Nord et al. 
(1993), e.g., saving one life is 
equivalent to returning 3 patients at 
the health state (112232) to full 
health 
Nord et al. 
(1995) 
Australia 




/ ex post 
simple choice exercise: 
allocation of fixed 
budget 





Nord et al. 
(1996) 
Australia 
176 respondents from 




maker / ex 
post 
PTO 
(1) age: the young are favored over the old 
(2) size of health gain: the larger gain is 
favored but at a diminishing rate 
Age weights are similar in two 
health gain scenarios: for 10, 20, 60 
and 80 years, the median weights 
are 1.1, 1.0, 0.4 and 0.1. 
The discounted rates for health gain 






recruited from an 
online panel broadly 




/ ex post 
DCE, weights 
calculated using the 
marginal rate of 
substitution 
(1) gender: insignificant 
(2) smoking status: no>yes 
(3) income/SES: low income > high income 
(4) lifestyle: healthy > not healthy 
(5) carer status: carer > non carer 
(6) age of death/remaining LE if untreated: 
45>60>75 
(7) extra LE if treated (health gain): the 
larger the better but a diminishing effect 
 
Weights for combination of 
attributes reported in Table 3 and 4 
of Norman et al. (2013) 
Olsen (2000) Norway 
716 respondents from 
the adult population in 
Norway 
Citizen / ex 
post 
choice exercise with 
bespoke design 
Distribution of fixed gain: there is a 
threshold level of benefits to the larger 
group above which people prefer to 
distribute gains to as many people as 






Olsen (2013) Norway 







/ ex post 
choice exercise with 
bespoke design 
(1) age: the young are favoured  
(2) size of gain: large gain is favoured  
(3) end of life: little support for the 
"end-of-life" argument that a short life 








a representative sample 
of 143 from Troms 
county  
Citizen / ex 
ante 
CVM 
type of health gains: life saving QALY 
gain > life extending QALY > QOL 
improving QALY (WTP/QALY: 2 NOK, 





a quota sample of 500 
respondents from the 




/ ex post 
 
DCE, weights 
estimated using the 
social welfare function 
based method 
 
(1) age: 1-19 > below 1 > 20-59 > 60+ 
(2) number of patients: significant positive 
effect 
(3) life-years saved: significant positive 
effect 
Based on model 1, the weights for 
life saving among age groups 
'below 1', '1-19', '20-59', and '60+' 
are 4, 5, 3, and 1. 
Pennington 










across nine European 
countries 
Personal / ex 
post 
CVM 
(1) type of gains: value for life extending 
gains > value for QOL enhancing gains 
(2)end of life: modest premium indicated for 




Petrou et al. 
(2013) 
UK 
2500 respondents from 
an internet panel in UK 
Impartial 
decision 
maker / ex 
post 
PTO 
age: the young are favored over the old, and 
30 is the most highly valued age 
Estimated weights vary according 
to different framings, age bases, 
and methods. In most cases, 
30-year-olds have the highest mean 
weight.  
Pinto-Prades 




of the Spain adult 
general population 
CVM: 





maker / ex 
post 
CVM and PTO 
(1) end of life premium: yes 
(2) type of gain: at the end of life, quality of 
life improvement > life extension 
The weights for end of life 
treatment and temporary health gain 
are around 1.5 to 1. The weights for 
QOL improvement at the end of life 
and life extension at the end of life 









maker / ex 
post 
PTO 
geographical equality of health gain 
distribution: preferred but not at any cost 
 
In the context of preventing 
children from diseases, the median 
respondent in both samples gives a 
weight of 0.8 to 1 for a health gain 
concentrated in region 1 and a 
health gain equally divided between 





et al. (2011) 
Australia 
 








/ ex post 
PTO, weights 
calculated as a function 
of TTO utility scores 
and severity measure 
(QOL loss) 
(1) severity of pre-treatment condition: 
highly significant  
(2) size of health gain: positive but 
diminishing 
See Table 7 of Richardson et al. 
(2011) 
Richardson 
et al. (2012) 
Australia 
 








maker / ex 
post 
choice exercise with 
bespoke design 
distribution of fixed gain: very strong 
preference for ‘dispersion’ of benefits rather 
than their ‘concentration’ 
  
Roberts et al. 
(1999) 
UK 
a random sample of 91 
respondents, broadly 
representative of the 
population of a health 




/ ex post 
DCE 
(1) the chance of success of the intervention: 
0.1%, 1%, 10%, 50% 
(2) the number of people receiving 
treatments: 1, 10, 100 
(3) survival gains if treatment is successful: 
1 year, 5 years 
(4) health state after treatment: good > poor  
(little support for health care programs that 
left patients in relatively poor health states 










a random sample of 49 
respondents recruited 




/ ex post 
DCE (called random 
paired scenarios in the 
paper) 
 
(1) age: child>old 
(2) severity of disease: severe > mild 
(3) prognosis: poor > good 
(4) cost of treatment: expensive > 
inexpensive 






a sample of 127 
respondents from an 




maker / ex 
post 
PTO 
improving patients' health > avoiding 
decline (cure > prevention) 
The mean substitution rate between 
health improvements and avoided 
decline ranged between 0.47 and 
0.64 dependent on the intervention. 







a random sample from 
an internet panel; 843 
completed the first 
survey; among them 




maker / ex 
ante 
choice experiments 
with allocation of 
points 
(1) age: children > employable age > 
teenager > seniors 
(2) combination of initial and post-treatment 
QOL: low–high > moderate–high > 
low–low > high-high 




plus 5 years > no effect > minus 5 years   
(4) frequency of the disease: common > rare 
(5) costs: below average > above average 
 
Shah et al. 
(2013) 
UK 
a quota sample of 50 
respondents broadly 
representative of the 
UK general population 
Social 
non-specific 
/ ex post 
choice exercise with 
bespoke design 
end of life: weak evidence of support for 
giving priority to the patient with shorter 
remaining life expectancy 






a random sample of 
2283 respondents from 
an online panel, 
broadly representative 
of Japanese general 
population 
Personal / ex 
post 
CVM 
(1) severity: more severe health state is 
valued higher 
(2) end of life premium: no 
  
Singh et al. 
(2012) 
UK 
a sample of 1030 
respondents 




/ ex post 
PTO 
self-induced/unhealthy lifestyle: less weight 
was given to interventions related to 
self-induced illness than that is caused by 
health care or nature (genetic disorders) 
The weights for genetic disorder, 
lifestyle disease, and sport injury 









/ ex post 
choice exercise: 
bespoke design 
social class: low > high (much stronger 







140 respondents from 
Yorks and Humberside 




/ ex post 
simple ranking exercise 
age: overall the young are favored over the 
old 
  
Ubel (1999) US 





/ ex post 
 
Q4,6: citizen 
/ ex ante 
simple choice exercise 
severity of illness: more severe is favoured 
but affected by framing effects 
  
Ubel et al. 
(1996) 
US 




/ ex post 
simple choice exercise 
distribution of fixed gain: a small gain to the 
many> a large gain to the few (strong 
preference for giving more a benefit) 
  
Ubel et al. 
(1998) 
US 
228 prospective jurors 




/ ex post 
choice exercise with 
bespoke design 
(1) severity: significant preference for 
directing limited resources toward those 
with greater disabilities, regardless of 
whether those resources were targeted 
toward prevention or cure.  
(2) prevention vs cure: when the magnitude 
of benefit was held constant, the subjects 




Ubel et al. 
(1999) 
US 
251 prospective jurors 
in Philadelphia ( not 
representative  but 




maker / ex 
post 
PTO 
treatment potential: lifesaving to perfect 
health has the same value as lifesaving to 
pre-existing paraplegia but much larger 
value than lifesaving to onset paraplegia 
(treatment causes paraplegia) and lifesaving 
to avoidable paraplegia (treatment causes 
paraplegia which is avoidable) 
lifesaving to perfect health vs 
lifesaving to pre-existing paraplegia 
vs lifesaving to onset paraplegia 
(treatment causes paraplegia) vs 
lifesaving to avoidable paraplegia 
(treatment causes paraplegia which 
is avoidable) = 1:1:50:5000 
Ubel et al. 
(2000) 
US 




/ ex post 
simple choice exercise 
 
distribution of fixed gain: preference for 








prospective jurors in 
Philadelphia; study 2: a 
sample of 68 




/ ex post 
simple choice exercise 
distribution of fixed gain: preference for 
giving more people gain is affected by 




Whitty et al. 
(2008) 
Australia 
a quasi-random sample 




/ ex post 
DCE 
 
(1) chance of success: significantly positive  
(2) average survival, for those in whom the 
new pharmaceutical is successful: 
significantly positive 
(3) average health-related QOL, for those in 
whom the new pharmaceutical is successful. 
If successfully treated, the recipient remains 
in this health state for the duration of their 
survival: No pain/discomfort > Moderate 
pain/discomfort > Extreme pain/discomfort 
(4) additional cost: significantly negative 
 
  
Whitty et al. 
(2011) 
Australia 
a quasi-random sample 
of 161 respondents 
Social 
non-specific 
/ ex post 
DCE 
(1) expected survival if untreated: short (3 
months) > long (15 years) 
(2) expected health state if untreated: poor 
(extreme pain/discomfort) > moderate 
(moderate pain/discomfort and moderate 
anxiety/depression) 
(3) success rate: 60% < 90% 
(4) survival gain if treated: significantly 
positive 
(5) QOL if treated: significantly positive 
(6) cost: significantly negative  




high < low 
 
Whitty et al. 
(2014) 
Australia 
930 respondents from 
an online panel 
(broadly representative 
of Queensland and 
Australia population 










/ ex ante 
DCE, BWS 
DCE:  
(1) benefit type: early diagnosis > 
prevention > survival improve >  hospital 
waiting time reduction > QOL 
improvement > side effect reduction  
(2) good value for money: yes > no  
(3) alternative treatment available: no 
alternatives > upgrade of an existing 
intervention > an alternative but different 
intervention is already available  
(4) number of patients: 
1000>=2000>500>10  
(5) age: 35>10>60>85  
(6) indigenous Queenslanders: yes > no  
(7) rural or remote area: yes > no  
BWS:  











120 respondents from 
Bremen, broadly 




/ ex post 
ranking exercise with 
experimental design 
mean preferences: 
(1) age: 16 > 37 > 68 
(2) healthy lifestyle: yes > no 
(3) type of illness: acute > chronic 
(4) severity of illness before treatment: 
severe > light 
(5) improvement in health after treatment: 
large > middle > small 





severity of illness before treatment: 19.6% 
improvement in health after treatment: 
19.5% 
healthy lifestyle: 15.3% 
treatment costs: 13.5% 






Appendix 3 Summary of results on ‘other attributes’ 
 
Other attributes of beneficiaries 
Four studies elicited preferences for beneficiaries who have dependents (Diederich, et al., 
2012; Dolan and Shaw, 2003; Linley and Hughes, 2013; Norman, et al., 2013). Three suggest 
the general public tends to favour individuals with dependents over those without dependents 
(Diederich, et al., 2012; Linley and Hughes, 2013; Norman, et al., 2013). The other study 
ranked having dependents as one of the least important attributes (Dolan and Shaw, 2003). 
Two studies elicited preference for marital status. Charny, et al. (1989) suggested that 
married people were favoured over singles while Diederich, et al. (2012) found that singles 
were favoured over those who are married. Charny, et al. (1989) found both employment 
status and gender had no impact on resource allocation. Whitty, et al. (2014) reported 
indigenous people and those living in rural or remote areas were favoured. 
Three studies elicited preference for QoL after treatment or the end health state (Bryan, et al., 
2002; Roberts, et al., 1999; Whitty, et al., 2008). All suggest little support for health care 
programmes that may leave patients in relatively poor health states even though this 
represents a prognostic improvement. A similar attribute is treatment potential (i.e. the best 
possible end health state) and Ubel, et al. (1999) found that individuals with less treatment 
potential were not disfavoured even if their gain from treatment was very limited.  
Two studies elicited preferences for the rarity of disease. Linley and Hughes (2013) reported 
that common diseases were favoured over rare diseases while Schwappach and Strasmann 
(2006) found that rarity of disease had no impact on resource allocation.  
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Two studies elicited preferences for lifetime QALYs (i.e., health from a specific time to 
death). Bleichrodt et al (2005) and Edlin et al (2012) both found people with fewer lifetime 
QALYs were favoured. Similarly, Dolan and Tsuchiya (2005a) elicited preferences for past 
QALYs (i.e., health experienced up to now) and found people with fewer past QALYs were 
favoured. Another study by Dolan and Tsuchiya (2005b) elicited preferences for past QoL 
(i.e., QoL of all the past years) and found people with less past QoL were favoured. All four 
papers interpreted their results using fair inning arguments. 
Other contextual attributes 
Three studies elicited preferences for availability of alternative treatment and all found that a 
disease with no alternative treatment was given priority (Green and Gerard, 2009; Linley and 
Hughes, 2013; Whitty, et al., 2014). Linley and Hughes (2013) found this preference 
remained even when the treatment led to limited health gain. Other attributes include number 
of patients (3 studies: larger number is favoured) (Bryan, et al., 2002; Palanca-Tan, 2013; 
Whitty, et al., 2014), chance of success (3 studies: higher chance is favoured) (Bryan, et al., 
2002; Whitty, et al., 2008; Whitty, et al., 2011), cost effectiveness (2 studies: more cost 
effective treatment is favoured) (Green and Gerard, 2009; Whitty, et al., 2014), and 
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